-
Fmoc-Val-Cit-OH
-
BD256986159858-21-695%
-
¥51.01g
-
4-((17S,20S)-1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-17-isopropyl-15,18-dioxo-20-(3-ureidopropyl)-3,6,9,12-tetraoxa-16,19-diazahenicosanamido)benzyl (4-nitrophenyl) carbonate
-
BD008562982112738-09-595%
-
¥2639.025mg
-
4-((2S,5S)-19-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-4,7,17-trioxo-2-(3-ureidopropyl)-10,13-dioxa-3,6,16-triazanonadecanamido)benzyl (4-nitrophenyl) carbonate
-
BD008566122112738-13-198%
-
¥5000.050mg
-
tert-Butyl ((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate
-
BD00782372870487-09-597%
-
¥613.0100mg
-
Fmoc-Val-Cit-PAB-PNP
-
BD221977863971-53-398%
-
¥305.0100mg
-
4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl (4-nitrophenyl) carbonate
-
BD293478159857-81-595%
-
¥331.0100mg
-
Val-Cit-PAB-OH
-
BD256991159857-79-198%
-
¥107.0100mg
-
Fmoc-Val-Cit-PAB-OH
-
BD256985159858-22-798%
-
¥52.0100mg
-
Boc-Val-Cit-OH
-
BD256987870487-08-497%
-
¥50.0250mg
-
6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide
-
BD00795530159857-80-499%
-
¥491.0100mg
-
tert-Butyl ((S)-3-methyl-1-(((S)-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-1-oxobutan-2-yl)carbamate
-
BD00784395870487-10-898%
-
¥1691.0250mg
-
4-((2S,5S)-37-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-4,7,35-trioxo-2-(3-ureidopropyl)-10,13,16,19,22,25,28,31-octaoxa-3,6,34-triazaheptatriacontanamido)benzyl (4-nitrophenyl) carbonate
-
BD014411521964490-09-295%
-
¥
-
Azido-peg4-val-cit-pab-oh
-
BD008124702055024-64-998%
-
¥12747.01g
-
OPSS-Val-Cit-PAB-PNP
-
BD01441770N/A95%
-
¥
-
4-((17S,20S)-1-(DBCO-Butanedicarboxylamino)-17-isopropyl-15,18-dioxo-20-(3-ureidopropyl)-3,6,9,12-tetraoxa-16,19-diazahenicosan-21-amido)benzyl (4-nitrophenyl) carbonate
-
BD014160322226472-28-095%
-
¥
-
4-((14S,17S)-1-Azido-14-isopropyl-12,15-dioxo-17-(3-ureidopropyl)-3,6,9-trioxa-13,16-diazaoctadecan-18-amido)benzyl (4-nitrophenyl) carbonate
-
BD011112932055047-18-098%
-
¥7720.050mg
-
OPSS-Val-Cit-PAB-OH
-
BD01456098N/A95%
-
¥
-
Bicyclo[6.1.0]non-4-yn-9-ylmethyl ((6S,9S)-1-amino-6-((4-(hydroxymethyl)phenyl)carbamoyl)-9-isopropyl-1,8,11-trioxo-14,17,20-trioxa-2,7,10-triazadocosan-22-yl)carbamate
-
BD01424034N/A95%
-
¥
-
1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)-3,6,9,12-tetraoxapentadecan-15-amide
-
BD008490352055041-39-798%
-
¥9322.0250mg
-
4-((S)-2-((S)-2-(3-(2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethoxy)propanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl (4-nitrophenyl) carbonate
-
BD012020302249935-92-896%
-
¥15783.0100mg